Sep 15, 2022 / 03:45PM GMT
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
Well, good day, everybody. Thanks for joining us at the BofA Healthcare Conference. My name is Jason Gerberry. I'm one of the biopharma analysts here at Bank of America. And I'm pleased to be introducing our next company Viatris, and we're joined by the team. We've got Michael Goettler, CEO; Rajiv Malik, President; and Sanjeev Narula, CFO. So gentlemen, thanks so much for joining us.
Michael Goettler - Viatris Inc. - CEO & Executive Director
Thanks, Jason.
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
I think, Michael, you may have a few prepared remarks first before we jump into Q&A or no?
Michael Goettler - Viatris Inc. - CEO & Executive Director
Not really prepared, but I want to thank you for inviting us to this. And Viatris -- it's almost 2 years old now, like in November will be our second anniversary. And yet, this because of
Viatris Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers